Biotech Acquisition Company (BIOTW)
$0.01
$-0.07
(-90.27%)
As on 02-Feb-2023 15:59EDT
Market cap
$278 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$8 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
25.57
-
EV/EBITDA
0
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$0.4
-
Face value
--
-
Shares outstanding
0
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Biotech Acquisition Company (BIOTW)
| -88.6 | -88.6 | -81.7 | -97.1 | -- | -- | -- |
|
BSE Sensex*
| -10.5 | -3.5 | 2.0 | -6.1 | 4.6 | 5.4 | 10.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Biotech Acquisition Company (BIOTW)
|
0.0 | 278.3 | 0.0 | 11.0 | -- | 5.2 | -- | 0.0 |
| 33.9 | 821.8 | 1,266.4 | 35.1 | 4.8 | 15.8 | 25.3 | 4.0 | |
| 52.0 | 1,979.3 | 6,872.0 | -16.0 | 0.1 | -29.9 | -- | 32.2 | |
| 16.9 | 585.6 | 4,063.1 | -273.4 | -2.5 | -27.9 | -- | 0.6 | |
| 23.3 | 808.0 | 4,063.1 | -273.4 | -2.5 | -27.9 | -- | 0.8 | |
| 54.5 | 976.6 | 1,344.4 | 36.5 | 3.9 | 29.4 | 25.7 | 7.8 | |
| 85.4 | 4,383.3 | 2,938.6 | 277.4 | 13.9 | 14.5 | 16.4 | 2.2 | |
| 62.0 | 2,882.5 | 18,718.1 | 104.2 | 1.9 | 5 | 27.7 | 1.3 | |
| 69.1 | 3,186.7 | 4,884.0 | 175.0 | 6.2 | 195.5 | 18.4 | 24.6 | |
| 8.8 | 1,097.9 | 787.3 | 101.8 | 17.8 | 16.4 | 11.3 | 1.9 |
Shareholding Pattern
View DetailsAbout Biotech Acquisition Company (BIOTW)
Biotech Acquisition Company is a blank check company. The company was incorporated in 2020 and is based in New York, New York.
-
Chairman & CEO
Dr. Michael Shleifer Ph.D.
-
Chairman & CEO
Dr. Michael Shleifer Ph.D.
-
Headquarters
New York, NY
-
Website
--
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Biotech Acquisition Company (BIOTW)
What is the current share price of Biotech Acquisition Company (BIOTW) Today?
The share price of Biotech Acquisition Company (BIOTW) is $0.01 (NASDAQ) as of 02-Feb-2023 15:59 EDT. Biotech Acquisition Company (BIOTW) has given a return of -97.14% in the last 1 years.
What is the current PB & PE ratio of Biotech Acquisition Company (BIOTW)?
Since, TTM earnings of Biotech Acquisition Company (BIOTW) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2021 |
-2.76 |
-702,351.85 |
2020 |
-- |
-- |
2021 |
-2.76 |
-702,351.85 |
2020 |
-- |
-- |
What is the 52 Week High and Low of Biotech Acquisition Company (BIOTW)?
The 52-week high and low of Biotech Acquisition Company (BIOTW) are Rs -- and Rs -- as of 08-Sep-2026.
What is the market cap of Biotech Acquisition Company (BIOTW)?
Biotech Acquisition Company (BIOTW) has a market capitalisation of $ 278 Mln as on 14-Feb-2023. As per SEBI classification, it is a company.
Should I invest in Biotech Acquisition Company (BIOTW)?
Before investing in Biotech Acquisition Company (BIOTW), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.